The effect of tadalafil on psychosocial outcomes in Swedish men with erectile distress: A multicentre, non-randomised, open-label clinical study

International Journal of Clinical Practice

Volumn 60, Issue 11, 2006, Pages 1386-1393

  Fugl Meyer, Kerstin S ^a   Stothard, D ^b   Belger, M ^b   Toll, A ^c   Berglund, O ^d   Eliasson, T ^c   Fugl Meyer, A R ^e  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b ELI LILLY AND COMPANY   (United States)

^c Eli Lilly Sweden AB   (Sweden)

^d Dragonens Hälsocentral   (Sweden)

^e UPPSALA UNIVERSITY   (Sweden)

Author keywords

Erectile distress; Erectile dysfunction; Intrapersonal relations; Life satisfaction; Tadalafil

Indexed keywords

TADALAFIL;

ADULT; AGED; ARTICLE; BACKACHE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISTRESS SYNDROME; DRUG TOLERABILITY; DRUG WITHDRAWAL; DYSPEPSIA; ERECTILE DYSFUNCTION; FAMILY LIFE; FLUSHING; HEADACHE; HUMAN; LIFE SATISFACTION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MYALGIA; OPEN STUDY; PENIS ERECTION; PRIORITY JOURNAL; RATING SCALE; SELF ESTEEM; SEXUAL BEHAVIOR; SEXUAL SATISFACTION; SIDE EFFECT; SOCIAL PSYCHOLOGY; STATISTICAL SIGNIFICANCE; SWEDEN; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; CARBOLINES; ERECTILE DYSFUNCTION; HUMANS; IMPOTENCE; INTERPERSONAL RELATIONS; MALE; MIDDLE AGED; PATIENT SATISFACTION; PHOSPHODIESTERASE INHIBITORS; QUALITY OF LIFE; QUESTIONNAIRES; SWEDEN; TREATMENT OUTCOME;

EID: 33749830105     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2006.01171.x     Document Type: Article

References (26)

1. Lewis RW, Fugl-Meyer KS, Bosch R et.al. Epidemiology/risk factors of sexual dysfunction. J Sex Med 2004; 1: 35-9.
2. Araujo AB, Johannes CB, Feldman HA et.al. Relation between psychosocial risk factors and incident erectile dysfunction: Prospective results from the Massachusetts male aging study. Am J Epidemiol 2000; 152: 533-41.
3. Aversa A, Isidori AM, Gianfrilli D et.al. Are subjects with erectile dysfunction aware of their condition? Results from a retrospective study based on an Italian free-call information service. J Endocrinol Invest 2004; 27: 548-56.
4. Feldman HA, Goldstein I, Hatzichristou DG et.al. Impotence and its medical and psychosocial correlates: Results of the Massachusetts Male Aging Study. J Urol 1994; 151: 54-61.
5. Lunenfeld B. The ageing male: Demographics and challenges. World J Urol 2002; 20: 11-6.
6. Fugl-Meyer AR, Lodnert G, Branholm IB, Fugl-Meyer KS. On life satisfaction in male erectile dysfunction. Int J Impot Res 1997; 9: 141-8.
7. Farre JM, Fora F, Lasheras MG. Specific aspects of erectile dysfunction in psychiatry. Int J Impot Res 2004; 16 (Suppl. 2): S46-9.
8. Mallis D, Moysidis K, Nakopoulou E et.al. Psychiatric morbidity is frequently undetected in patients with erectile dysfunction. J Urol 2005; 174: 1913-6.
9. American Psychiatric Association. DSM-IV: Diagnostic and Statistical Manual of Mental Disorders, 4th edn. Arlington, VA: American Psychiatric Press, 1994.
10. Fugl-Meyer K, Fugl-Meyer AR. Sexual disabilities are not singularities. Int J Impot Res 2002; 14: 487-93.
11. Carson CC, Rajfer J, Eardley I et.al. The efficacy and safety of tadalafil: An update. BJU Int 2004; 93: 1276-81.
12. Lewis RW, Sadovsky R, Eardley I et.al. The efficacy of tadalafil in clinical populations. J Sex Med 2005; 2: 517-31.
13. Forgue ST, Patterson BE, Bedding AW et.al. Tadalafil pharmacokinetics in healthy subjects. Br J Clin Pharmacol 2006; 61: 280-8.
14. Young JM, Feldman RA, Auerbach SM et.al. Tadalafil improved erectile function at twenty-four and thirty-six hours after dosing in men with erectile dysfunction: US trial. J Androl 2005; 26: 310-8.
15. Swindle RW, Cameron AE, Lockhart DC, Rosen RC. The psychological and interpersonal relationship scales: Assessing psychological and relationship outcomes associated with erectile dysfunction and its treatment. Arch Sex Behav 2004; 33: 19-30.
16. Fugl-Meyer A, Fugl-Meyer K. Sexual disabilities, problems and satisfaction in 18-74year old Swedes. Scand J Sexol 1999; 2: 79-105.
17. Fugl-Meyer KS, Helmius G, Lalos A, Mansson S-A. This is a book whelebook. In: Lewin B, ed. Sex in Sweden, On the Swedish Sexual Life. Stockholm: Swedish National Institute of Public Health, 1998 (English translation, 2000).
18. Fugl-Meyer KS. Health, sexual ability and quality of life. In: Lewin B, ed. Sex in Sweden, On the Swedish Sexual Life. Stockholm: Swedish National Institute of Public Health, 1998: 217-34 (English translation, 2000).
19. Rosen RC, Riley A, Wagner G et.al. The international index of erectile function (IIEF): A multidimensional scale for assessment of erectile dysfunction. Urology 1997; 49: 822-30.
20. Cappelleri JC, Rosen RC, Smith MD et.al. Diagnostic evaluation of the erectile function domain of the international index of erectile function. Urology 1999; 54: 346-51.
21. Fugl-Meyer AR, Melin R, Fugl-Meyer KS. Life satisfaction in 18- to 64-year-old Swedes: In relation to gender, age, partner and immigrant status. J Rehabil Med 2002; 34: 239-46.
22. Rosen R, Broderick G, Shabsigh R et.al. Sensitivity of the psychological and interpersonal relationship scales to oral therapies for erectile dysfunction. J Sex Med 2005; 2: 461-8.
23. Mallis D, Moisidis K, Kirana P-S et.al. Moderate and severe erectile dysfunction equally affects life satisfaction. J Sex Med 2006; 3: 442-449.
24. Micholas AC. Satisfaction and happiness. Soc Indic Res 1980; 8: 385-422.
25. Gil A, Martinez E, Oyaguez I et.al. Erectile dysfunction in a primary care setting: Results of an observational, no-control-group, prospective study with sildenafil under routine conditions of use. Int J Impot Res 2001; 13: 338-47.
26. Rosen R, Montorsi F, Assalian P et.al. Efficacy and tolerability of vardenafil in men with mild major depressive disorder and erectile dysfunction: The depression related improvement with vardenafil for erectile response (Driver) study. Eur Urol Suppl 2004; 3: 235.